The execution engine for expert-driven, AI‑accelerated global health innovation

The execution engine for expert-driven, AI‑accelerated global health innovation

The execution engine for expert-driven, AI‑accelerated global health innovation

Salution Nexus propels innovation to global impact.

Salution Nexus is the execution engine and trusted partner for organizations that choose to lead, not follow. We accelerate the next generation of diagnostic and therapeutic technologies toward global impact.

We exist to make breakthrough innovation not just possible, but predictable, scalable, and successful.

Why we exist

The pace and complexity of modern medical innovation have outstripped the capacity of even the largest healthcare organizations to manage the full product lifecycle internally. Advanced diagnostics and therapeutics including AI-enabled devices, software as a medical device, and cell and gene-based products now demand a breadth of expertise that is technically deep, operationally complex, capital-intensive, and continuously evolving.
 
Success today requires expertise across the entire continuum: unmet needs identification, product ideation, health economics, lead generation, preclinical development, manufacturing, clinical trial design, regulatory strategy and submissions, quality systems, and post-market surveillance. Few organizations can sustain excellence across all of these domains on their own.

Closing the gap

Salution Nexus exists to close that gap.
 
Salution Nexus delivers clarity, rigor, and execution power for the most complex innovation challenges in healthcare. As a fully integrated human + AI–powered health accelerator, we combine world-class human expertise with AI-enabled speed and accuracy to turn breakthrough ideas into approvable, scalable, and commercially successful medical products worldwide.
 
A tightly integrated, purpose-built, agentic AI platform for medical product lifecycle management, coupled with a senior operating team of clinician-scientists, engineers, AI and data science leaders, and executives with deep leadership experience across the FDA, academia, and industry, underpins our success. 

About Salution Nexus

Salution Nexus accelerates innovation in healthcare, bringing human expertise and AI together to navigate real-world clinical and regulatory complexity.

Artificial
Intelligence

The digital backbone for operational intelligence, analytics, and automation

Human

Experts

The frontline engine for innovation and commercialization across the full lifecycle

Artificial
Intelligence

The digital backbone for operational intelligence, analytics, and automation

Human

Experts

The frontline engine for innovation and commercialization across the full lifecycle

About Salution Nexus

Salution Nexus accelerates innovation in healthcare, bringing human expertise and AI together to navigate real-world clinical and regulatory complexity.

Artificial
Intelligence

The digital backbone for operational intelligence, analytics, and automation

Salution
Nexus

The frontline engine for innovation and commercialization across the full lifecycle

Ready to move your medical innovation forward?

We provide end-to-end support, from early concept and preclinical planning through clinical trial design and execution, global regulatory approvals, and post-market evidence generation.

We combine deep FDA regulatory expertise, robust clinical and scientific capabilities, and AI-powered precision to help turn breakthrough ideas into approvable, scalable, and commercially successful medical products.

Team

Led by world-class experts spanning health innovation, regulation, and clinical AI⁠-⁠supported by a global partner network.

Camille Ortiz

Malvina B. Eydelman, MD

Co-Founder, President and CEO

Executive Chair, Collaborative Community of Ophthalmic Innovation (CCOI) Adjunct Professor, Byers Eye Institute World-renowned Medical Innovation Expert

Tieuvi Nguyen, PhD

Executive Vice President

Elvin Y. Ng

Vice President

Jessica Harris

Chief Financial Officer

Phil Kallos

AI Architect

Noah Dennis

Advisor

Chris Chaplin

AI Engineer

Anahit Khshtoyan

Project Manager

Board

Experienced leaders guiding our vision and execution.

Mark Blumenkranz, MD, MMS

Co-Founder, Executive Chairman

HJ Smead Professor of Ophthalmology Emeritus, Stanford University Founding Director, Byers Eye Institute World-renowned Clinician and Innovator

Camille Ortiz

Malvina B. Eydelman, MD

Co-Founder, President and CEO

Executive Chair, Collaborative Community of Ophthalmic Innovation (CCOI) Adjunct Professor, Byers Eye Institute World-renowned Medical Innovation Expert

Aman Mahajan, MD, PHD, MBA

Board Member

Amir Dan Rubin, MBA

Board Member

Emmett Cunningham Jr., MD, PhD, MPH

Board Member